BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 29290656)

  • 1. Early gastric cancer frequently has high expression of KK-LC-1, a cancer-testis antigen.
    Futawatari N; Fukuyama T; Yamamura R; Shida A; Takahashi Y; Nishi Y; Ichiki Y; Kobayashi N; Yamazaki H; Watanabe M
    World J Gastroenterol; 2017 Dec; 23(46):8200-8206. PubMed ID: 29290656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation Between Expression of the Cancer/Testis Antigen KK-LC-1 and
    Fukuyama T; Futawatari N; Ichiki Y; Shida A; Yamazaki T; Nishi Y; Nonoguchi H; Takahashi Y; Yamazaki H; Kobayashi N
    In Vivo; 2017; 31(3):403-407. PubMed ID: 28438869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequent High Expression of Kita-Kyushu Lung Cancer Antigen-1 (KK-LC-1) in Gastric Cancer.
    Shida A; Futawatari N; Fukuyama T; Ichiki Y; Takahashi Y; Nishi Y; Kobayashi N; Yamazaki H; Watanabe M
    Anticancer Res; 2015 Jun; 35(6):3575-9. PubMed ID: 26026129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of immunohistochemical expression of cancer/testis tumor-associated antigens (MAGE-A1, MAGE-A3/4, NY-ESO-1) in patients with non-small cell lung cancer.
    Grah JJ; Katalinic D; Juretic A; Santek F; Samarzija M
    Tumori; 2014; 100(1):60-8. PubMed ID: 24675493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of cancer/testis antigens expression in patients with non-small cell lung cancer.
    Shigematsu Y; Hanagiri T; Shiota H; Kuroda K; Baba T; Mizukami M; So T; Ichiki Y; Yasuda M; So T; Takenoyama M; Yasumoto K
    Lung Cancer; 2010 Apr; 68(1):105-10. PubMed ID: 19545928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohystochemical expression of cancer/testis antigens (MAGE-A3/4, NY-ESO-1) in non-small cell lung cancer: the relationship with clinical-pathological features.
    Grah J; Samija M; Juretić A; Sarcević B; Sobat H
    Coll Antropol; 2008 Sep; 32(3):731-6. PubMed ID: 18982744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Demethylation of MAGE promoters during gastric cancer progression.
    Honda T; Tamura G; Waki T; Kawata S; Terashima M; Nishizuka S; Motoyama T
    Br J Cancer; 2004 Feb; 90(4):838-43. PubMed ID: 14970862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of cancer-testis antigens MAGE-A3/6 and NY-ESO-1 in non-small-cell lung carcinomas and their relationship with immune cell infiltration.
    Kim SH; Lee S; Lee CH; Lee MK; Kim YD; Shin DH; Choi KU; Kim JY; Park DY; Sol MY
    Lung; 2009; 187(6):401-11. PubMed ID: 19795170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive and prognostic effect of CD133 and cancer-testis antigens in stage Ib-IIIA non-small cell lung cancer.
    Su C; Xu Y; Li X; Ren S; Zhao C; Hou L; Ye Z; Zhou C
    Int J Clin Exp Pathol; 2015; 8(5):5509-18. PubMed ID: 26191258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of MAGE-A and NY-ESO-1 in Primary and Metastatic Cancers.
    Park TS; Groh EM; Patel K; Kerkar SP; Lee CC; Rosenberg SA
    J Immunother; 2016 Jan; 39(1):1-7. PubMed ID: 26641256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of GAGE, NY-ESO-1 and SP17 cancer/testis antigen expression in early stage non-small cell lung carcinoma.
    Gjerstorff MF; Pøhl M; Olsen KE; Ditzel HJ
    BMC Cancer; 2013 Oct; 13():466. PubMed ID: 24103781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and clinical significance of MAGE and NY-ESO-1 cancer-testis antigens in adenoid cystic carcinoma of the head and neck.
    Veit JA; Heine D; Thierauf J; Lennerz J; Shetty S; Schuler PJ; Whiteside T; Beutner D; Meyer M; Grünewald I; Ritter G; Gnjatic S; Sikora AG; Hoffmann TK; Laban S
    Head Neck; 2016 Jul; 38(7):1008-16. PubMed ID: 26874246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer/testis antigen expression and specific cytotoxic T lymphocyte responses in non small cell lung cancer.
    Groeper C; Gambazzi F; Zajac P; Bubendorf L; Adamina M; Rosenthal R; Zerkowski HR; Heberer M; Spagnoli GC
    Int J Cancer; 2007 Jan; 120(2):337-43. PubMed ID: 17066423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KK-LC-1 may be an effective prognostic biomarker for gastric cancer.
    Ji J; Chen J; Wang A; Zhang W; Ju H; Liu Y; Li L
    BMC Cancer; 2021 Mar; 21(1):267. PubMed ID: 33711953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of NY-ESO-1, MAGE-A3, PRAME and WT1 in different subgroups of breast cancer: An indication to immunotherapy?
    Tessari A; Pilla L; Silvia D; Duca M; Paolini B; Carcangiu ML; Mariani L; de Braud FG; Cresta S
    Breast; 2018 Dec; 42():68-73. PubMed ID: 30189381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined cancer testis antigens enhanced prediction accuracy for prognosis of patients with hepatocellular carcinoma.
    Wang M; Li J; Wang L; Chen X; Zhang Z; Yue D; Ping Y; Shi X; Huang L; Zhang T; Yang L; Zhao Y; Ma X; Li D; Fan Z; Zhao L; Tang Z; Zhai W; Zhang B; Zhang Y
    Int J Clin Exp Pathol; 2015; 8(4):3513-28. PubMed ID: 26097535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and prognostic significance of cancer-testis antigens (CTA) in intrahepatic cholagiocarcinoma.
    Zhou JX; Li Y; Chen SX; Deng AM
    J Exp Clin Cancer Res; 2011 Jan; 30(1):2. PubMed ID: 21211023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MAGE-A3/4 and NY-ESO-1 antigens expression in metastatic esophageal squamous cell carcinoma.
    Bujas T; Marusic Z; Peric Balja M; Mijic A; Kruslin B; Tomas D
    Eur J Histochem; 2011 Mar; 55(1):e7. PubMed ID: 21556122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Expression of Melanoma-Associated Antigen D2 Both in Surgically Resected and Serum Samples Serves as Clinically Relevant Biomarker of Gastric Cancer Progression.
    Kanda M; Nomoto S; Oya H; Takami H; Shimizu D; Hibino S; Hashimoto R; Kobayashi D; Tanaka C; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
    Ann Surg Oncol; 2016 Feb; 23 Suppl 2():S214-21. PubMed ID: 25743330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Case-Control Study: Smoking History Affects the Production of Tumor Antigen-Specific Antibodies NY-ESO-1 in Patients with Lung Cancer in Comparison with Cancer Disease-Free Group.
    Myšíková D; Adkins I; Hradilová N; Palata O; Šimonek J; Pozniak J; Kolařík J; Skallová-Fialová A; Špíšek R; Lischke R
    J Thorac Oncol; 2017 Feb; 12(2):249-257. PubMed ID: 27793776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.